You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 1, January 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

WHO Neuropsychiatric AIDS Study, Cross-sectional Phase II

Neuropsychological and Neurological Findings

Mario Maj, MD, PhD; Paul Satz, PhD; Robert Janssen, MD; Michael Zaudig, MD; Fabrizio Starace, MD; Lou D'Elia, PhD; Bhirom Sughondhabirom, MD; Mahamoudi Mussa, MD; Dieter Naber, MD; David Ndetei, MD; George Schulte, MD; Norman Sartorius, MD, PhD

Arch Gen Psychiatry. 1994;51(1):51-61.


Abstract

Background
The neuropsychological and neurological complications of HIV-1 infection and AIDS were explored within the cross-sectional phase of the WHO Neuropsychiatric AIDS Study. Special attention was devoted to the controversial issue of the prevalence and clinical significance of subtle cognitive deficits in asymptomatic seropositive subjects.

Methods
A neuropsychological test battery validated for cross-cultural use, a structured interview for the diagnosis of dementia, a rating scale of functioning in daily living activities, and a neurological module were administered to representative samples of seropositive subjects and to matched seronegative controls living in the five geographic areas predominantly affected by the HIV-1 epidemic. Data are available for five centers.

Results
The prevalence of global neuropsychological impairment was significantly increased in asymptomatic seropositive subjects compared with controls in only two centers. A significant effect of education on neuropsychological performance was observed among asymptomatic seropositive individuals. In the two African centers, low-education, but not high-education, asymptomatic seropositive persons had an impaired performance. The frequency of impaired functioning in daily living activities and of neurologic abnormalities was higher in symptomatic, but not in asymptoatic, seropositive subjects compared with controls in all centers.

Conclusions
These data suggest that the risk of subtle cognitive deficits may be increased in asymptomatic stages of HIV-1 infection. However, these deficits are not associated with neurologic changes and do not seem to affect subjects' social functioning.



Author Affiliations

From the Division of Mental Health and Global Programme on AIDS, World Health Organization, Geneva, Switzerland (Drs Maj, Starace, and Sartorius); the Department of Psychiatry I, University of Naples (Italy) (Drs Maj and Starace); the Neuropsychiatric Institute, UCLA, Los Angeles, Calif (Drs Satz and D'Elia); the Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Janssen); the Max-Planck Institute for Psychiatry, Munich, Germany (Dr Zaudig); the Department of Psychiatry, Chulalongkorn University, Bangkok, Thailand (Dr Sughondhabirom); the Centre of Neuropsychopathology, University of Kinshasa, and the Projet SIDA, Kinshasa, Zaire (Dr Mussa); the Department of Psychiatry, University of Munich (Germany) (Dr Naber); the Department of Psychiatry, University of Nairobi (Kenya) (Dr Ndetei); and the Emilio Ribas Hospital, São Paulo, Brazil (Dr Schulte).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Prevalence of Depression Among Men Living With HIV Infection in Vietnam
Esposito et al.
AJPH 2009;99:S439-S444.
ABSTRACT | FULL TEXT  

Closing Gaps in Antiretroviral Therapy Access: Human Immunodeficiency Virus-Associated Dementia Screening Instruments for Non-Physician Healthcare Workers
Kvalsund et al.
Am J Trop Med Hyg 2009;80:1054-1059.
ABSTRACT | FULL TEXT  

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda
Sacktor et al.
Neurology 2009;72:165-170.
ABSTRACT | FULL TEXT  

Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection
Valcour et al.
Neurology 2007;68:525-527.
ABSTRACT | FULL TEXT  

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
Wong et al.
Neurology 2007;68:350-355.
ABSTRACT | FULL TEXT  

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor et al.
Neurology 2006;67:311-314.
ABSTRACT | FULL TEXT  

The Global HIV/AIDS Epidemic and Related Mental Health Issues: The Crisis for Africans and Black Americans
Fitzpatrick et al.
Journal of Black Psychology 2004;30:11-23.
ABSTRACT  

Risk Factors for Cognitive Impairment in HIV-1-Infected Persons With Different Risk Behaviors
De Ronchi et al.
Arch Neurol 2002;59:812-818.
ABSTRACT | FULL TEXT  

Cognitive Function in Asymptomatic HIV Infection
Damos et al.
Arch Neurol 1997;54:179-185.
ABSTRACT  

Delayed Latency of the Event-Related Brain Potential P3A Component in HIV Disease: Progressive Effects With Increasing Cognitive Impairment
Fein et al.
Arch Neurol 1995;52:1109-1118.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.